Safety of Medicines - urgent action needed

According to the WHO alert, the four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup. Attached images.

"To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products," the alert said, adding that laboratory analysis of samples of the products "confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants."

Those substances are toxic to humans and can be fatal, it said, adding that the toxic effect "can include abdominal pain, vomiting, diarrhoea, inability to pass urine, headache, altered mental state and acute kidney injury which may lead to death."

We really must get Govt to act on this so atleast from a DCGI standpoint there arent loop holes and a perception building that Indian pharma is not trust worthy.

Also we need to know what of these toxic syrups have been sold within India rural or urban more  

via_LocalCircles_0079E441-CB74-4AFB-9000-9B14FBA4DAEF___20221006010018___.jpeg
View all 11 comments Below 11 comments
Premature scare mongering and mud slinging. The contents of every drug are revealed on the container and carton, which are generally in a language readable by WHO. If any medicine, when tested, should reasonably confirm to that contents and any testing authority finds to the contrary, should divulge the results to both the manufacturer and regulatory authority of the country concerned instead of premature speculation. This is an attempt to defame the Indian Pharmaceutical Industry, over which most of the world depends. WHO has only said this so far - “ The manufacturer of these products “to date, has not provided guarantees to WHO on the safety and quality of these products” It’s imprudent for us Indians to make a mountain out of this mischievous and perhaps motivated action by WHO. more  
Doubt cast on our controlling authorities, the DCGI as well, who also had the responsibility for checking the drug consignment being delivered to the African nation. How did the Haryana based company Maiden Pharmaceuticals continue having a license to manufacture the drug! Can't rely entirely upon the manufacturer, when some products cross our borders. None of the company's employees, or offices after the above happening, was contactable. Despite all the celebratory messages about Make in India, touted too as being the pharmacy of the world, this incident draws and directs our attention towards how much India's commitment towards safety of medicine is wrong. more  
Heart rending! Instead of glycerin, the cough syrup contained unacceptable amounts of diethylene glycol and ethylene glycol as contaminants, which did the damage! Paediatric medicines must be milder than those taken by adults, while in this case such was the drugs standard! Glycerin, being hygroscopic substance, many a times used for diluting in oral medicines which must be made milder, since they pass the same passage through the human body as food. Simple logic. Government's safeguards should have been in place. Shocking! more  
looks like our drugs controller dept is taking a nap when these kinds of activities are happening under their nose and going un reported.How did they get approval from them very surprising.There will be lot of these kind of drugs in circulation without the knowledge of our DCI.It is high time that medical shops should be made to keep medicines which are approved by DCI and also need to be seen which doctor has prescribed these syrups.Looks like they got percentage commission for prescribing these syrups.DCI need to immediately ask all medical shops to destroy stocks what they have of the above medicines.There is lot of activities which they have to initiate immediately and hope they wake up from their nap. more  
Sri. Nishat Khan, "a perception building that Indian pharma is not trust worthy"... Unfortunately, to me it not a "perception", it is reality. more  
Post a Comment

Related Posts

    • Lift safety issues persist

      Yesterday in Noida a lift went through the tower roof because of maintenance negligence. See attached.

      By Radha Puri
      /
    • Hallmarking of Gold Jewellery

      This latest survey of LC is good as it helps consumers in not getting cheated or misled https:...

      By Aditi Mitra
      /
    • Why no red label on brain damaging products like Coke and Pepsi

      Why is the Government not putting front of the pack red labels on drinks like pepsi and coke. 10 year olds are drinking 5-6 glasses in a birthday party. Drinking Coca-Cola or Pepsi: This...

      By Shikha Chhabra
      /
    • Rising health insurance premiums

      Is a very serious issue and I am glad that LocalCircles has taken it up. In UP the survey was published in the navbharat times and i am attaching for this who read hindi.

      By RN Chopra
      /
    • Health insurance premium increase

      The reliable Indian Express paper is quoting our circle survey and saying that health insurance premiums for 52% people who have personal policy have risen by 25% or more in last 12 months.

      By Neelima Verma
      /
    • deteriorating services of health insurance services.

      This is really a true picture of current scenario. Despite increase in premium amount continuously in ;ast 2-3 years after covid, service standards have drastically gone from bad to worst by these ...

      By Alok Khullar
      /
    • Plight of health Insurance claimants

      I must complement localcircles management and members for being the most effective media in the country to quantify public plight on various issues and bringing it out. The attached sto...

      By Aditi Gupta
      /
    • Average temp going up by 5-8 degrees

      See attached friends. Average summer have gone up in India by 5-8 degrees in last 5 years. Like this we will have 50 degrees in Delhi soon. This is climate change for us.

      By Sudesh Rai
      /
    • Why households are facing squeeze

      The most important parameter for judging any government is the inflation vs. increased incomes. A study was conducted in Maharashtra on the cost of making two thalis in 2019 and 2024. The data used...

      By Reeta Kumar
      /
    • Covishield Astrazeneca has a problem

      AstraZeneca, for the first time, admitted in its court documents that its Covid vaccine can cause rare side effects, paving way for a multi-million pound legal payout, The Telegraph reported on Sun...

      By Ruchika L Maheshwari
      /
    • Elon Musk mocking India

      Musk canceled his visit to India "because of a busy schedule." He arrived in China today but could not find time to fly five hours southwest. Despite having 1/6th of the world's population, India i...

      By Shivani Khiste
      /
Share
Enter your email and mobile number and we will send you the instructions

Note - The email can sometime gets delivered to the spam folder, so the instruction will be send to your mobile as well

All My Circles
Invite to
(Maximum 500 email ids allowed.)